1921
Volume 80, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

is the etiologic agent of the muscle-spasming disease tetanus. Despite an effective vaccine, tetanus is an ongoing problem in some developing countries. Diagnosis by bacterial culture is not done because it is generally unnecessary and the entry of route of the bacteria can be inapparent. We attempted to isolate and evaluate from the wounds of 84 patients with tetanus. We effectively isolated from 45 patients. All strains tested positive by polymerase chain reaction for the gene encoding tetanus neurotoxin. Antimicrobial susceptibilities were determined by disc diffusion and E-test. All isolates were susceptible to penicillin and metronidazole but resistant to co-trimoxazole. Despite treatment with high doses of penicillin, was isolated after 16 days of intravenous penicillin in two cases. These data show that the intravenous route for penicillin may be inadequate for clearing the infection and emphasizes wound debridement in the treatment of tetanus.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2009.80.827
2009-05-01
2017-09-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/80/5/0800827.html?itemId=/content/journals/10.4269/ajtmh.2009.80.827&mimeType=html&fmt=ahah

References

  1. Thwaites CL, Yen LM, Nga NT, Parry J, Binh NT, Loan HT, Thuy TT, Bethell D, Parry CM, White NJ, Day NP, Farrar JJ, 2004. Impact of improved vaccination programme and intensive care facilities on incidence and outcome of tetanus in southern Vietnam, 1993–2002. Trans R Soc Trop Med Hyg 98 : 671–677.
  2. Dietz V, Milstien JB, van Loon F, Cochi S, Bennett J, 1996. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull World Health Organ 74 : 619–628.
  3. Whitman C, Belgharbi L, Gasse F, Torel C, Mattei V, Zoffmann H, 1992. Progress towards the global elimination of neonatal tetanus. World Health Stat Q 45 : 248–256.
  4. Udwadia FE, 1994. Tetanus. Oxford: Oxford University Press.
  5. Wilkins CA, Richter MB, Hobbs WB, Whitcomb M, Bergh N, Carstens J, 1988. Occurrence of Clostridium tetani in soil and horses. S Afr Med J 73 : 718–720.
  6. Mellanby J, Green J, 1981. How does tetanus toxin act? Neuroscience 6 : 281–300.
  7. Cook TM, Protheroe RT, Handel JM, 2001. Tetanus: a review of the literature. Br J Anaesth 87 : 477–487.
  8. Farrar JJ, Yen LM, Cook T, Fairweather N, Binh N, Parry J, Parry CM, 2000. Tetanus. J Neurol Neurosurg Psychiatry 69 : 292–301.
  9. Fairweather NF, Lyness VA, 1986. The complete nucleotide sequence of tetanus toxin. Nucleic Acids Res 14 : 7809–7812.
  10. Fairweather NF, Lyness VA, Pickard DJ, Allen G, Thomson RO, 1986. Cloning, nucleotide sequencing, and expression of tetanus toxin fragment C in Escherichia coli. J Bacteriol 165 : 21–27.
  11. Bruggemann H, Baumer S, Fricke WF, Wiezer A, Liesegang H, Decker I, Herzberg C, Martinez-Arias R, Merkl R, Henne A, Gottschalk G, 2003. The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc Natl Acad Sci USA 100 : 1316–1321.
  12. Campbell J, Farrar J, 2002. Antimicrobial Therapy and Vaccines. Volume I, Microbes. New York: Appletrees Productions.
  13. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, 1995. Manual of Clinical Microbiology, Sixth Edition. Washington, DC: ASM Press.
  14. Hatheway CL, 1990. Toxigenic Clostridia. J Micro Rev 3 : 66–98.
  15. Clinical and Laboratory Standards Institute, 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. MS100-S17. CLSI, Wayne, PA.
  16. Nagao K, Mori T, Sawada C, Sasakawa C, Kanezaki Y, 2007. Detection of the tetanus toxin gene by polymerase chain reaction: a case study. Jpn J Infect Dis 60 : 149–150.
  17. Bruggemann H, 2005. Genomics of clostridial pathogens: implication of extrachromosomal elements in pathogenicity. Curr Opin Microbiol 8 : 601–605.
  18. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, Thomson NR, Roberts AP, Cerdeno-Tarraga AM, Wang H, Holden MT, Wright A, Churcher C, Quail MA, Baker S, Bason N, Brooks K, Chillingworth T, Cronin A, Davis P, Dowd L, Fraser A, Feltwell T, Hance Z, Holroyd S, Jagels K, Moule S, Mungall K, Price C, Rabbinowitsch E, Sharp S, Simmonds M, Stevens K, Unwin L, Whithead S, Dupuy B, Dougan G, Barrell B, Parkhill J, 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38 : 779–786.
  19. Ganesh Kumar AV, Kothari VM, Krishnan A, Karnad DR, 2004. Benzathine penicillin, metronidazole and benzyl penicillin in the treatment of tetanus: a randomized, controlled trial. Ann Trop Med Parasitol 98 : 59–63.
  20. Thwaites CL, Farrar JJ, 2003. Preventing and treating tetanus. BMJ 326 : 117–118.
  21. Kabura L, Ilibagiza D, Menten J, Van den Ende J, 2006. Intrathecal vs. intramuscular administration of human antitetanus immunoglobulin or equine tetanus antitoxin in the treatment of tetanus: a meta-analysis. Trop Med Int Health 11 : 1075–1081.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2009.80.827
Loading
/content/journals/10.4269/ajtmh.2009.80.827
Loading

Data & Media loading...

  • Received : 12 Nov 2008
  • Accepted : 18 Jan 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error